BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

452 related articles for article (PubMed ID: 31105018)

  • 21. Validation of the fibrosis-4 (FIB-4) index in the diagnosis of liver disease of rheumatoid arthritis patients treated with methotrexate.
    Miyata M; Kuroda M; Unakami M; Tasaki K; Migita K; Ohira H
    Mod Rheumatol; 2019 Nov; 29(6):936-942. PubMed ID: 30379089
    [No Abstract]   [Full Text] [Related]  

  • 22. Folic acid and cyanocobalamin levels in serum and erythrocytes during low-dose methotrexate therapy of rheumatoid arthritis and psoriatic arthritis patients.
    Leeb BF; Witzmann G; Ogris E; Studnicka-Benke A; Andel I; Schweitzer H; Smolen JS
    Clin Exp Rheumatol; 1995; 13(4):459-63. PubMed ID: 7586777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for abnormal hepatic enzyme elevation by methotrexate treatment in patients with rheumatoid arthritis: A hospital based-cohort study.
    Hakamata J; Hashiguchi M; Kaneko Y; Yamaoka K; Shimizu M; Maruyama J; Takeuchi T; Mochizuki M
    Mod Rheumatol; 2018 Jul; 28(4):611-620. PubMed ID: 29252093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk of liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis receiving methotrexate: A population-based study.
    Gelfand JM; Wan J; Zhang H; Shin DB; Ogdie A; Syed MN; Egeberg A
    J Am Acad Dermatol; 2021 Jun; 84(6):1636-1643. PubMed ID: 33607181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Usefulness of daily folic acid supplementation during methotrexate treatment of Japanese patients with rheumatoid arthritis.
    Sasaki K; Tsuji T; Kimoto Y; Yanagihara Y; Masuguchi K; Chikamori A; Watanabe H; Murakami T; Oryoji D; Hashimoto M; Horiuchi T; Egashira N
    Mod Rheumatol; 2021 Jan; 31(1):108-113. PubMed ID: 32167789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate-induced pneumonitis in patients with rheumatoid arthritis and psoriatic arthritis: report of five cases and review of the literature.
    Salaffi F; Manganelli P; Carotti M; Subiaco S; Lamanna G; Cervini C
    Clin Rheumatol; 1997 May; 16(3):296-304. PubMed ID: 9184269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long-term methotrexate therapy. Followup over long treatment intervals and correlation with clinical and laboratory variables.
    Kremer JM; Kaye GI; Kaye NW; Ishak KG; Axiotis CA
    Arthritis Rheum; 1995 Sep; 38(9):1194-203. PubMed ID: 7575712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoimmune hepatitis as an adverse effect of long-term methotrexate therapy.
    Ksouda K; Affes H; Atheymen R; Ezzeddine M; Zeghal K; Hammami S
    Indian J Pharmacol; 2014; 46(6):649-50. PubMed ID: 25538339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of two different folic acid doses with methotrexate--a randomized controlled trial (FOLVARI Study).
    Dhir V; Sandhu A; Kaur J; Pinto B; Kumar P; Kaur P; Gupta N; Sood A; Sharma A; Sharma S
    Arthritis Res Ther; 2015 Jun; 17(1):156. PubMed ID: 26063325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reduction of the efficacy of methotrexate by the use of folic acid: post hoc analysis from two randomized controlled studies.
    Khanna D; Park GS; Paulus HE; Simpson KM; Elashoff D; Cohen SB; Emery P; Dorrier C; Furst DE
    Arthritis Rheum; 2005 Oct; 52(10):3030-8. PubMed ID: 16200612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of High-Dose Folic Acid on Methotrexate Efficacies and Safety in Japanese Rheumatoid Arthritis Patients.
    Kameyama S; Kase Y; Kurihara S; Yoshida F; Noda M; Iiduka T; Horiguchi M; Sugiyama K; Hirano T
    Drug Res (Stuttg); 2017 Dec; 67(12):705-709. PubMed ID: 28898908
    [No Abstract]   [Full Text] [Related]  

  • 32. The long-term effect of methotrexate therapy on the liver in patients with juvenile rheumatoid arthritis.
    Hashkes PJ; Balistreri WF; Bove KE; Ballard ET; Passo MH
    Arthritis Rheum; 1997 Dec; 40(12):2226-34. PubMed ID: 9416861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of less frequent monitoring of liver transaminases levels in rheumatic patients treated with low-dose methotrexate.
    Khabbazi A; Kolahi S; Dastgiri S; Hajialiloo M; Nazeri M; Nazeri L; Sheikholeslami Salmasi A; Gader S; Bak Mohammad Zadeh S; Ghasemi A; Poormohammad A
    Int J Rheum Dis; 2014 Jul; 17(6):646-52. PubMed ID: 24965662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatoprotective effect of berberine against methotrexate induced liver toxicity in rats.
    Mehrzadi S; Fatemi I; Esmaeilizadeh M; Ghaznavi H; Kalantar H; Goudarzi M
    Biomed Pharmacother; 2018 Jan; 97():233-239. PubMed ID: 29091871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y; Erkan D; Harrison MJ; Nikolov NP; Paget SA
    Clin Exp Rheumatol; 2005; 23(4):517-20. PubMed ID: 16095122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.
    van Ede AE; Laan RF; Blom HJ; Huizinga TW; Haagsma CJ; Giesendorf BA; de Boo TM; van de Putte LB
    Arthritis Rheum; 2001 Nov; 44(11):2525-30. PubMed ID: 11710708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatotoxicity associated with low-dose, long-term methotrexate treatment of rheumatoid arthritis.
    Szanto E; Sandstedt B; Kollberg B
    Scand J Rheumatol; 1987; 16(4):229-34. PubMed ID: 3629206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatoprotective effect of tumour necrosis factor alpha blockade in psoriatic arthritis: a cross-sectional study.
    Seitz M; Reichenbach S; Möller B; Zwahlen M; Villiger PM; Dufour JF
    Ann Rheum Dis; 2010 Jun; 69(6):1148-50. PubMed ID: 19854710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
    Spadaro A; Riccieri V; Sili-Scavalli A; Sensi F; Taccari E; Zoppini A
    Clin Exp Rheumatol; 1995; 13(5):589-93. PubMed ID: 8575136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methotrexate and hepatic toxicity in rheumatoid arthritis and psoriatic arthritis.
    Tilling L; Townsend S; David J
    Clin Drug Investig; 2006; 26(2):55-62. PubMed ID: 17163236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.